The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AMAZON COM INC | COM | 023135106 | 2,940,194 | 16,300 | SH | SOLE | 16,300 | 0 | 0 | |||
| AMPHENOL CORP NEW | CL A | 032095101 | 1,153,500 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
| CURTISS WRIGHT CORP | COM | 231561101 | 1,126,136 | 4,400 | SH | SOLE | 4,400 | 0 | 0 | |||
| DIGITAL RLTY TR INC | COM | 253868103 | 2,880,800 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | |||
| EQUINIX INC | COM | 29444U700 | 3,301,320 | 4,000 | SH | SOLE | 4,000 | 0 | 0 | |||
| IQIYI INC | NOTE 6.500% 3/1 | G4939KAF3 | 28,343,750 | 30,000,000 | PRN | SOLE | 30,000,000 | 0 | 0 | |||
| SNOWFLAKE INC | CL A | 833445109 | 1,189,376 | 7,360 | SH | SOLE | 7,360 | 0 | 0 | |||
| YS BIOPHARMA CO LTD | *W EXP 03/15/202 | G9845F117 | 53,700 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | |||